tm logo
QUREDOSE
Live/Registered
REGISTERED

on 01 Aug 2023

Last Applicant/ Owned by

Paasheuvelweg 25

Amsterdam

NL

1105BP

Serial Number

90788287 filed on 22nd Jun 2021

Registration Number

7123802 registered on 01st Aug 2023

in the Principal Register

Correspondent Address

Julianne Abelman

Womble Bond Dickinson (US) LLP

950 3rd Avenue, Suite 2400

New York, NY 10022

Filing Basis

1. intent to use

Disclaimer

NO DATA

QUREDOSE

Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics

Class [042]
Computer & Software Services & Scientific Services


Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics

Class [005]
Pharmaceutical Products


Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products for the treatment of viral diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy, namely, biological preparations for medical diagnostic or treatment use; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy

Mark Details


Serial Number

No 90788287

Mark Type

No Service Mark

Attorney Docket Number

No 115710.00731

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Aug 2023REGISTERED-PRINCIPAL REGISTER
01st Aug 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
26th Jun 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
26th Jun 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
01st May 2023TEAS DELETE 1(B) BASIS RECEIVED
01st May 2023NOTICE OF ALLOWANCE CANCELLED
25th Apr 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28th Feb 2023PUBLISHED FOR OPPOSITION
28th Feb 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08th Feb 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED